tiprankstipranks
Analyst Profile
Followed by 725 other investors
.
Sandy Draper

Sandy Draper

Guggenheim
Wall Street Analyst
Ranked #162 out of 8,047 Analysts on TipRanks (#212 out of 21,521 overall experts)

Success Rate

67%
165 out of 247 Profitable Transactions

Average Return

20.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Sandy Draper's ratings since 2015 and opened each position for the duration of 1 Year:
66.80% of your transactions would have been profitable with an average return of 20.0%

Stock Rating Distribution

394Ratings
68.78% Buy
30.71% Hold
0.51% Sell
Distribution of Sandy Draper's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Evolent Health Inc.
(EVH)
Rating Type:Buy
Dates:Mar 26, 2020 - Mar 26, 2021
Gain:250.50%
The most profitable rating made by Sandy Draper

Sandy Draper's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Quest Diagnostics
Hold
Upgraded
0.00%
1
Everyday Health
Hold
Downgraded
100%
+28.20%
4
WebMD Health
Hold
Downgraded
88%
+20.95%
10
The Advisory Board
Hold
Reiterated
100%
+15.73%
11
Parexel
Hold
Reiterated
0%
-13.25%
14
Cotiviti Holdings
Hold
Downgraded
67%
+20.96%
10
Athenahealth
Hold
Downgraded
50%
+4.91%
11
Medidata Solutions
Hold
Downgraded
100%
+13.10%
11
Change Healthcare
Hold
Downgraded
$25.75
(4.76% Upside)
80%
+70.02%
6
Premier
Hold
Reiterated
$38.00
(-1.12% Downside)
100%
+20.82%
11
List of latest recommendations made by Sandy Draper. Click to expand and see Sandy Draper's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More